Immunology
-
Structure and computation-guided design of a mutation-integrated trimeric RBD candidate vaccine with broad neutralization against SARS-CoV-2
This article has 33 authors:Reviewed by ScreenIT
-
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
This article has 10 authors:Reviewed by ScreenIT
-
Circulating multimeric immune complexes drive immunopathology in COVID-19
This article has 18 authors:Reviewed by ScreenIT
-
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
This article has 17 authors:Reviewed by ScreenIT
-
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
This article has 15 authors:Reviewed by ScreenIT
-
Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
This article has 17 authors:Reviewed by ScreenIT
-
The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patients
This article has 26 authors:Reviewed by ScreenIT
-
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
This article has 11 authors:Reviewed by ScreenIT
-
Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
This article has 18 authors:Reviewed by ScreenIT
-
A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants
This article has 25 authors:Reviewed by ScreenIT